MedTrace Logo

LAnguage-Motor Imagery Circuits to Improve Motor Learning and Language Comprehension

NCT06478303 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 105

Last updated 2024-08-02

No results posted yet for this study

Summary

Recent evidence suggests that cognitive systems do not operate in isolation but interact within broader networks, thus opening new avenues for fundamental and clinical research. An illustrative example is the interaction between language comprehension and motor representations. For instance, motor training (e.g., sports, origami training) can facilitate action verb recognition, whereas motor deficits (e.g., upper limb immobilization) can hinder the processing of action language. Similarly, action language has been shown to affect motor performance. These effects are attributed to an implicit form of motor imagery, an automatic simulation of motor experience (without actual movement) evoked by action words. Interestingly, literature supports the idea that the motor simulations used for imagining an action are also engaged during the reading of action language, leading to similar neurophysiological and behavioral changes in both processes. However, questions remain about the similarity of the simulations generated by motor imagery and action language. This project, encompassing three experimental sequences, aims to address these questions to achieve significant scientific advancements in both theoretical and applied domains.

Conditions

  • Corticospinal Excitability
  • Cortical Activation

Interventions

OTHER

Motor imagery

Participants were asked to imagine arm or foot movements.

OTHER

Action reading

Participants were asked to read sentences involving arm or foot movements

OTHER

Motor localizer

Participants were asked to perform arm or foot movements

Sponsors & Collaborators

  • University of Burgundy

    collaborator OTHER

  • University Hospital, Grenoble

    lead OTHER

Principal Investigators

  • Laurent VERCUEIL · CHU Grenoble Alpes

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-07-27
Primary Completion
2027-07-26
Completion
2028-07-26

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06478303 on ClinicalTrials.gov